NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Autonomix Medical, Inc. (AMIX) Stock Analysis

Autonomix Medical, Inc. (AMIX) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

AMIX

$2.57

−$0.04 (−1.53%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AMIX with… →

AMIX Key Statistics

As of Oct 21, 2026
Trading
Open
$2.61
Previous Close
$2.61
Day's Range
2.57–2.64
52-Week Range
2.44–32.55
Volume
14.73K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.94
Valuation
Market Cap
$5.04M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−39.67
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$16.72M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
1.96M
1-Year Return
−88.97%
Dividend and dates
Avg Volume
4.46M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AMIX closed at $2.57, −88.97% over 1 year.

Autonomix Medical, Inc. (AMIX) has a market capitalization of $5.04M.

In fiscal 2025, AMIX reported revenue of $0.00.

AMIX Stock Return by Calendar Year

Autonomix Medical, Inc. (AMIX) return since Jan 2024: what $10,000 became

1 year
$10,000 $1,103
−88.97%
Since Jan 2024
$10,000 $12
−99.88%

If you had invested $10,000 in Autonomix Medical, Inc. (AMIX) at the close on January 29, 2024, the earliest close on record here, it would have been worth $12 at the close on October 21, 2026: −99.88% in total, −91.49% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−77.75%
2025−85.37%
2024−96.29%

As of October 21, 2026.

AMIX Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$16.72M—
2024$0.00−$11.41M—
2023$0.00−$15.43M—
2022$0.00−$1.99M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$17.03M−$16.72M—
2024$0.00—−$11.59M−$11.41M—
2023$0.00—−$7.47M−$15.43M—
2022$0.00—−$1.99M−$1.99M—

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

Recent News

All 12 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Autonomix Medical, Inc. (AMIX) carries a market capitalisation of $5.04M. It is classified in the Medical Devices industry, within the Healthcare sector.

The 52-week range on file runs from $2.44 to $32.55. The most recent close on file for AMIX is $2.57, dated October 21, 2026. That is −$0.04 (−1.53%) against the previous close. The latest close sits 5.33% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $0.00. The same year closed with a net loss of $16.72M. Trailing earnings per share are −39.67.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published.

The reported beta is −0.94. Daily returns over the trailing 2 years annualize to a volatility of 340.55%. Over the trailing twelve months the total return is −88.97%. The stored price history starts on January 29, 2024, and the total return since then is −99.88%.

Growth & Income

No dividend is on file for AMIX.

Across the complete calendar years on file, 2025 returned −85.37% and 2024 returned −96.29%. So far in 2026 the total return is −77.75%.

Peer Comparison

Autonomix Medical, Inc. (AMIX) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Autonomix Medical, Inc. AMIX $5.04M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Autonomix Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Autonomix Medical, Inc.

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Visit website →